Singapore, Feb. 25 -- CPHI Middle East and BIO Middle East are set to position Saudi Arabia at the forefront of the global life sciences sector with international industry titans confirmed to headline... Read More
Singapore, Feb. 25 -- US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Japan by Chugai Pharmaceutical, following its reimbursement ... Read More
Singapore, Feb. 25 -- How would you characterise Europe's biotech position today compared with the US and Asia as we move into 2026? As of 2026, Europe maintains a strong scientific foundation but fa... Read More
Singapore, Feb. 24 -- Taiwan-headquarteredBora Pharmaceuticals, a global leader in pharmaceutical manufacturing, and British pharma firmGSKhave signed a strategic agreement to renew a five-year manufa... Read More
Singapore, Feb. 24 -- Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN(R) dual-mas... Read More
Singapore, Feb. 24 -- Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new-generation cAMP-biased GLP... Read More
Singapore, Feb. 24 -- The KK Women's and Children's Hospital (KKH) Maternal and Child Health Research Institute (MCHRI) has launched Singapore's first set ofGuidelines on Management of the Menopause T... Read More
Singapore, Feb. 23 -- Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreementwith Arrotex Pharmaceuticals, for exclusive rights to the commercialisation of clobetasol pr... Read More
Singapore, Feb. 20 -- Expecto Health Science, a Singapore-headquartered, Asia-focused clinical research organization (CRO), and Southern Star Research (SSR), a leading Australia-based CRO, announced a... Read More
Singapore, Feb. 20 -- Japan-based Shimadzu Corporation has invested in A-wave Inc., a startup originating from The University of Osaka, through its Corporate Venture Capital (CVC) fund, "Shimadzu Futu... Read More